Back to Journals » Open Access Rheumatology: Research and Reviews » Volume 3

Combination therapy versus celecoxib, a single selective COX-2 agent, to reduce gastrointestinal toxicity in arthritic patients: patient and cost-effectiveness considerations
Total article views | Abstract views | HTML views | PDF downloads | Totals | |
---|---|---|---|---|---|
10,773 | Dovepress* | 8,963 | 566+ | 4,321 | 9,529 |
PubMed Central* | 0 | 1,244 | 92 | 1,244 | |
Totals | 8,963 | 1,810 | 4,413 | 10,773 | |
*Since 4 August 2011 +Since July 2016 |
View citations on PubMed Central and Google Scholar